Serum high-density lipoprotein cholesterol is significantly associated with the presence and severity of pulmonary arterial hypertension: a retrospective cross-sectional …

GF Wang, LH Guan, DX Zhou, DD Chen, XC Zhang… - Advances in …, 2020 - Springer
Introduction To explore the relationship between serum high-density lipoprotein cholesterol
(HDL-C) levels and the presence and severity of pulmonary arterial hypertension (PAH) …

Plasma levels of high-density lipoprotein cholesterol and outcomes in pulmonary arterial hypertension

GA Heresi, M Aytekin, J Newman… - American journal of …, 2010 - atsjournals.org
Rationale: High-density lipoprotein cholesterol (HDL-C) promotes healthy vascular function,
and it is decreased in insulin resistance. Insulin resistance predisposes to pulmonary …

Serum high-density lipoprotein cholesterol levels as a prognostic indicator in patients with idiopathic pulmonary arterial hypertension

QH Zhao, FH Peng, H Wei, J He, FD Chen… - The American journal of …, 2012 - Elsevier
High-density lipoprotein (HDL) cholesterol levels are a strong, independent inverse
predictor of cardiovascular disease. The present study aimed to determine whether serum …

Usefulness of high-density lipoprotein cholesterol to predict survival in pulmonary arterial hypertension

CM Larsen, RB McCully, JG Murphy… - The American journal of …, 2016 - Elsevier
It has been suggested that lipoprotein abnormalities may contribute to the pulmonary
arteriolar dysfunction observed in pulmonary arterial hypertension (PAH). High-density …

[HTML][HTML] Plasma levels of high density lipoprotein cholesterol and outcomes in chronic thromboembolic pulmonary hypertension

G Khirfan, V Tejwani, X Wang, M Li, J DiDonato… - PLoS …, 2018 - journals.plos.org
Background High Density Lipoprotein Cholesterol (HDL-C) has various anti-inflammatory,
anti-atherogenic, anti-oxidant and anti-coagulant properties that improve vascular function …

[HTML][HTML] Triglyceride-to-high-density lipoprotein cholesterol ratio and systemic inflammation in patients with idiopathic pulmonary arterial hypertension

K Jonas, W Magoń, P Podolec… - Medical science monitor …, 2019 - ncbi.nlm.nih.gov
Background Idiopathic pulmonary arterial hypertension (IPAH) patients are characterized by
elevated triglyceride (TG)-to-HDL cholesterol (HDL-C) ratio, which has been proposed to be …

[HTML][HTML] Low-density lipoprotein cholesterol and survival in pulmonary arterial hypertension

G Kopeć, M Waligóra, A Tyrka, K Jonas, MJ Pencina… - Scientific reports, 2017 - nature.com
Low-density lipoprotein cholesterol (LDL-C) is a well established metabolic marker of
cardiovascular risk, however, its role in pulmonary arterial hypertension (PAH) has not been …

[HTML][HTML] Differential serum lipid distribution in IPAH and CHD-PAH patients

J Chen, A Rathinasabapathy, J Luo, X Yang, P Luo… - Respiratory …, 2022 - Elsevier
Lipid homeostasis is dysregulated in pulmonary arterial hypertension (PAH). A decrease in
serum high-and low-density lipoprotein cholesterol (HDL-C and LDL-C) is significantly …

[HTML][HTML] HDL cholesterol as a marker of disease severity and prognosis in patients with pulmonary arterial hypertension

K Jonas, G Kopeć - International Journal of Molecular Sciences, 2019 - mdpi.com
The impact of high-density lipoprotein (HDL) cholesterol on the development of
atherosclerosis and diseases of systemic circulation has been well documented both in …

[PDF][PDF] Prognostic role of traditional cardiovascular risk factors in patients with idiopathic pulmonary arterial hypertension

K Jonas, M Waligóra, W Magoń, T Zdrojewski… - Archives of Medical …, 2019 - termedia.pl
Results The study group included 61 IPAH patients, and the control group included 2413
Polish residents. When compared to the general population, IPAH patients had lower low …